Early Prediction of Critical Care Interventions From Pediatric Emergency Department Triage
Abstract
BACKGROUND AND OBJECTIVES: Most pediatric emergency departments (EDs) in the United States use Emergency Severity Index (ESI) system to triage patients. Because the 5-level classification provides limited risk stratification, this study aims to improve patient prioritization by developing an operationally useful model that predicts risk of critical care interventions using only information available during ED triage.
METHODS: We conducted a retrospective study at a large urban academic pediatric ED from 2016 to 2024. We developed predictive models using 6 machine learning (ML) algorithms. Models were evaluated on Average Precision and tradeoff between sensitivity and positive predictive value (PPV). We performed a counterfactual analysis to assess potential clinical effects of risk predictions on timeliness of evaluation for critical care patients.
RESULTS: Among 886 183 ED visits, 26 721 (3.0%) received critical care interventions. The neural network had the highest Average Precision of 0.6 (95% CI 0.59-0.61). The model could identify 88% (87%-89%) of patients who received critical care interventions with PPV of 32% (31%-32%). Supplementing ESI with these risk predictions would have increased the proportion of critical care patients being timely evaluated by physicians from 23.3% to 75.0% for ESI 3 patients. Similarly, improvements would have been achieved for other ESI levels.
CONCLUSION: We developed models capable of quickly identifying ED pediatric patients at risk of…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.